AnalystBook Research · Company Intelligence

PHIBRO ANIMAL HEALTH CORP

PAHCNasdaq

Built from PHIBRO ANIMAL HEALTH CORP's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 27.4% to $1.30B, while Net income increased 1897.7% to $48.3M.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue $1.30BOK
  • ProfitabilityNet income $48.3MOK
  • Cash generationFree cash flow $41.8MOK
  • AccountingFormula-grey distress score · no manipulation flag · earnings quality safeNote
  • Insiders0 buys; 71 sells in 365 daysNote
  • Capitaldividends paid were $19.4MNote

Business

PHIBRO ANIMAL HEALTH CORP: 4 ​ Market, Ranking and Other Industry Data Unless otherwise indicated, information contained in this report concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity and market share, is based on management estimates.

Where the revenue comes from

Fiscal 2025, as PHIBRO ANIMAL HEALTH CORP reports it. History and quarterly detail are in the app.

  • Animal Health$962.8M
  • Mineral Nutrition$253.2M
  • Performance Products$80.2M

Leadership changes

From PHIBRO ANIMAL HEALTH CORP's own filings, the day they're filed.

  • Jack C. Bendheim · Executive Chairman · appointmenteff. 2026-07-01
  • Joyce J. Lee · director · appointmenteff. 2025-01-21
  • Todd Armstrong · President · appointmenteff. 2024-12-31

Latest filings

  • 8-K · Company announcement2026-08-26
  • 10-K · Annual report2026-08-26
  • 8-K · Company announcement2026-07-28
  • 8-K · Company announcement2026-06-26
  • 10-Q · Quarterly report2026-05-06
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about PHIBRO ANIMAL HEALTH CORP, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.